Unique to Medicare, both GLP1s and SGLT2s have gained ground, making up 23% and 17% of the market respectively by mid2025
human relevance of this finding has not been determined
The Precision Peptide Genetic Test analyzes 150+ genetic insights across 14 metabolic pathways, including your GIPR variants, which influence how strongly you respond to semaglutide
De Lisi, S., Leandro, G
Ideal candidates are typically over 40 and dissatisfied with their inability to lose weight, decreased sexual function, or a decline in energy level and cognitive function
Patients experiencing persistent skin dryness, unusual texture changes, or delayed wound healing should discuss nutritional assessment with their healthcare provider, though a direct causal relationship between GLP-1 therapy and specific nutritional deficiencies has not been firmly established